Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
J Natl Cancer Inst Monogr ; 2024(66): 282-289, 2024 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-39108235

RESUMEN

BACKGROUND: The benefits of cannabis in symptom management among cancer survivors are widely acknowledged; however, patterns of cannabis use by cancer stage at diagnosis are unknown. METHODS: Here, we examined the association between cancer stage at diagnosis and consideration of cannabis use since diagnosis. We analyzed cross-sectional survey data from 954 cancer survivors, weighted to be representative of a National Cancer Institute-Designated Comprehensive Cancer Center's patient population. We used survey-weighted multivariable logistic regression to examine the association between cancer stage at diagnosis (advanced [III/IV] versus non-advanced [I/II]) and consideration of cannabis use (yes versus no) since diagnosis. RESULTS: Sixty percent of the population was diagnosed with non-advanced stages of cancer, and 42% had considered using cannabis since diagnosis. The odds of consideration of cannabis use were 63% higher (odds ratio = 1.63, 95% confidence interval = 1.06 to 2.49) among cancer survivors diagnosed at stages III/IV than among those diagnosed at stages I/II. CONCLUSION: Cancer stage may be a predictor of consideration of cannabis use after diagnosis.


Asunto(s)
Supervivientes de Cáncer , Estadificación de Neoplasias , Neoplasias , Humanos , Supervivientes de Cáncer/estadística & datos numéricos , Femenino , Masculino , Persona de Mediana Edad , Estudios Transversales , California/epidemiología , Neoplasias/epidemiología , Adulto , Anciano , Adulto Joven
2.
J Natl Cancer Inst Monogr ; 2024(66): 244-251, 2024 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-39108239

RESUMEN

BACKGROUND: Many patients with cancer use cannabis to help alleviate untreated cancer symptoms and side effects. METHODS: We examined associations of perceived benefits and risks and postdiagnosis cannabis use in a weighted sample of adult cancer survivors through a 1-time survey. Fifteen perceived cannabis use benefits and 19 perceived risks were operationalized as both summary scores and report of any benefits or risks. Survey-weighted logistic regression provided covariate-adjusted odds of postdiagnosis cannabis use for each benefit-risk measure. RESULTS: Among the weighted population of 3785 survivors (mean [SD] age = 62.2 [13.5] years), one-third used cannabis after diagnosis. Perceiving any benefits increased the odds of postdiagnosis cannabis use more than 500%, and perceiving any risks lowered the odds by 59%. Each SD increase in endorsed benefits doubled the odds of postdiagnosis cannabis use, while each SD increase in endorsed risks reduced the odds by 36%. CONCLUSION: An accurate understanding of benefits and risks is critical for informed decision making.


Asunto(s)
Supervivientes de Cáncer , Neoplasias , Humanos , Femenino , Masculino , Persona de Mediana Edad , Neoplasias/diagnóstico , Neoplasias/epidemiología , Neoplasias/psicología , Supervivientes de Cáncer/estadística & datos numéricos , Supervivientes de Cáncer/psicología , Anciano , Medición de Riesgo , Adulto , Marihuana Medicinal/uso terapéutico , Marihuana Medicinal/efectos adversos , Encuestas y Cuestionarios/estadística & datos numéricos , Percepción , Cannabis/efectos adversos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...